Literature DB >> 10984570

Cancer immunotherapy with alloreactive lymphocytes.

S Slavin.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10984570     DOI： 10.1056/NEJM200009143431109

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  Hematologic aspects of myeloablative therapy and bone marrow transplantation.

Authors:  Roger S Riley; Michael Idowu; Alden Chesney; Shawn Zhao; John McCarty; Lawrence S Lamb; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

2.  Site-specific mutations in the mature form of human IL-18 with enhanced biological activity and decreased neutralization by IL-18 binding protein.

Authors:  S H Kim; T Azam; D Y Yoon; L L Reznikov; D Novick; M Rubinstein; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

Review 3.  Treatment of leukemia by alloreactive lymphocytes and nonmyeloablative stem cell transplantation.

Authors:  Shimon Slavin; Arnon Nagler; Michael Y Shapira; Mehmet Aker; Cividalli Gabriel; Reuven Or
Journal:  J Clin Immunol       Date:  2002-03       Impact factor: 8.317

4.  Radiobiological basis of low-dose irradiation in prevention and therapy of cancer.

Authors:  Myron Pollycove
Journal:  Dose Response       Date:  2006-11-27       Impact factor: 2.658
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.